Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relationship Between microRNAs in Breast Cancer Subtypes and Response to Neoadjuvant Chemotherapy and Pathological Response

NCT07289282 is registered in ClinicalTrials.gov with Atlas University as lead sponsor.

NCT NCT07289282
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07289282 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relationship Between microRNAs in Breast Cancer Subtypes and Response to Neoadjuvant Chemotherapy and Pathological Response
Lead sponsor
Atlas University
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2025
Completion date
December 31, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, invasive breast carcinoma, micrornas, neoadjuvant therapy, pathological response